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a  b  s  t  r  a  c  t
Root  preparations  of  Krameria  lappacea  (Dombey)  Burdet  et Simpson  are  traditionally  used  against
oropharyngeal  inﬂammation.  Besides  antimicrobial  and  astringent  procyanidines,  lignan  derivatives,
including  ratanhiaphenol  I, II, III and  (+)-conocarpan,  contribute  to the  activity  of  Ratanhiae  radix,  exerting
a  signiﬁcant  topical  anti-inﬂammatory  activity  in  vivo,  and  in  vitro  by inhibiting  NF-B  and  the  formation
of  inﬂammatory  prostaglandins  and  leukotrienes.  Besides  gravimetrical  analysis  of the  ratanhiaphenols
I,  II and  III,  the  content  of  these  compounds  in  the  herbal  drug  has never  been  determined.  The  devel-
oped  HPLC  method  enables  the  quantiﬁcation  of  twelve  active  lignan  derivatives  in the  roots,  and  is  also
suitable for  the  determination  of  the  constituents  in  Tinctura  Ratanhiae.  Separation  was  achieved  on  a
phenyl-hexyl  column  material  using  a solvent  gradient  consisting  of  0.02%  aqueous  TFA  and  a  mixture  ofPLC–PDA
PLC–MS
incture
acetonitrile/methanol  (75:25,  v/v).  Sensitivity,  accuracy  (recovery  rates  were  between  95%  and  105.6%),
repeatability  (RSD  ≤  4.6%),  and  precision  (intra-day  precision  ≤  4.8%;  inter-day  precision  ≤ 3.4%)  of  the
method  were  determined.  HPLC–MS  experiments  in positive  and  negative  electrospray  ionization  mode
conﬁrmed  identity  and  peak  purity  of analytes.  The  analysis  of several  root  and  tincture  samples  revealed
that  (+)-conocarpan  and  ratanhiaphenol  II dominated  with  contents  of 0.49–0.71%  and  0.51–0.53%  in  the
roots  and  0.66–0.68  mg/ml  and  0.70–0.71  mg/ml  in  the  commercial  tinctures,  respectively.. Introduction
Krameria lappacea (Dombey) Burdet et Simpson; (syn. K. trian-
ra Ruiz et Pavon), Krameriaceae, is a hemiparasitic shrub, which
s native to South America [1].  The plant is known as “raiz de
ientes” because it has traditionally been used in South Amer-
ca as chewing sticks for cleaning and strengthening teeth. Other
raditional indications are diarrhoea and mouth ulcer [1].  The
rug was introduced into European medicine over 200 years ago
s a remedy against stomach aches, diarrhoea, menstrual prob-
ems, nose bleeds and oropharyngeal inﬂammation [2,3]. Today
he drug and its preparation, an ethanolic tincture, are listed in
he European Pharmacopoeia, and the ESCOP Supplement 2009,
espectively. The therapeutic indications comprise mild inﬂam-
ations of mouth and throat such as stomatitis, gingivitis and
haryngitis [4].
The roots comprise 2 prominent compound classes: medium-
o-high molecular weight oligomeric proanthocyanidins [5],  with a
ontent of approximately 10%, and a set of lignan derivatives [6–8].
esides already known antimicrobial, antioxidant, and photopro-
∗ Corresponding author at: Institute of Pharmacy, University of Innsbruck, Inns-
ruck, Austria. Tel.: +43 512 507 5300; fax: +43 512 507 2939.
E-mail address: Hermann.Stuppner@uibk.ac.at (H. Stuppner).
731-7085 © 2011 Elsevier B.V. 
oi:10.1016/j.jpba.2011.06.016
Open access under CC BY-NC-ND license.© 2011 Elsevier B.V. 
tective properties [3,5,7,9] of root extracts, we  could demonstrate
in a previous study the pronounced anti-inﬂammatory activity of a
dichloromethane extract as well as of 11 isolated lignan derivatives
(compounds 1–6 and 8–12). The topical anti-inﬂammatory prop-
erties of the secondary metabolites were comparable to the drug
indomethacin (ID50 value 0.3 mol/cm2) in vivo, with ID50 values
ranging from 0.3 mol/cm2 to 0.6 mol/cm2. The in vitro evaluation
revealed NF-B, cyclooxygenase-1/2, 5-lipoxygenase, and micro-
somal prostaglandin E synthase-1 as responsible targets for the
activity against inﬂammation [10].
These pharmacological ﬁndings make a quality assessment of
Ratanhiae radix and its preparations with an adequate analytical
method with focus on the class of lignan derivatives, necessary.
The content of these compounds in the drug, besides a gravimet-
rical analysis of the ratanhiaphenols I, II and III (content of 0.3%)
[11] has never been determined to our knowledge. Two HPLC–MS
or GC–MS studies published until now enabled only the iden-
tiﬁcation of a limited number of lignan derivatives in different
extracts or tinctures of K. lappacea [9,12].  Therefore we developed
an efﬁcient and according to the ICH guidelines validated HPLC
method for the quantiﬁcation of the active constituents in the roots
Open access under CC BY-NC-ND license.as well as in the ethanolic tincture. One prominent constituent
of the investigated extracts (3-formyl-2-(4-hydroxyphenyl)-5-(E)-
propenylbenzofuran; compound 7), an additional lignan derivative,
was  isolated in course of the present study. HPLC–MS experiments
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ere carried out in order to conﬁrm purity and identity of the
nalytes.
. Experimental
.1. Materials
All solvents used for isolation were purchased from VWR
nternational (Darmstadt, Germany). Acetonitrile, methanol, and
riﬂuoroacetic acid (TFA) were of HPLC grade, and purchased from
erck (Darmstadt, Germany). Ultrapure water was  produced by
 Sartorius Arium® 611 UV water puriﬁcation system (Göttingen,
ermany). Polyamide 6 S was purchased from Riedel-de Haën
Seelze, Germany).
Quality of root samples of K. lappacea complied with the Euro-
ean Pharmacopoeia. RR-1 (batch number 212 965) and RR-2
batch number A902194-002) were purchased from Mag. pharm.
ottas-Heldenberg and Sohn (Vienna, Austria). Sample RR-3 (batch
umber 913075) was obtained from Kwizda Kräutergroßhandel
Linz, Austria). Voucher specimens are deposited at the Institute
f Pharmacy/Pharmacognosy, University of Innsbruck. Tincture 1
T-1), a kind gift from the Institute of Pharmacy/Pharmaceutical
echnology, University of Innsbruck, was prepared according to the
ustrian Pharmacopoeia but with a reduced maceration time of 3
ays. Tinctures 2–4 (commercial tinctures; T-2 to T-4; batch num-
ers 80516159, 80516419, and 1403/0409 1509) were purchased
rom different pharmacies in Austria. The quality of those complied
ith the Austrian Pharmacopoeia.
.2. Standards
Compounds 1–6, and 8–12 were isolated and their structures
lucidated in a previous study [10]. Compound 7 was isolated
s following: ground roots of K. lappacea (RR-1; 300 g) were
xhaustively extracted with dichloromethane (DCM) in a Soxhlet
pparatus (30 ◦C, 5 days). The extract was evaporated to dryness
ielding 16.32 g. 15.50 g of the obtained extract were separated
y ﬂash silica gel 60 (40–63 m,  Merck, Darmstadt, Germany)
olumn chromatography (270 g, 50 × 4 cm)  using a gradient with
etroleum ether (PE) and increasing the amount of a ﬁxed mixture
f DCM–ethyl acetate (EtOAc) (95:5, v/v), followed by increas-
ng the EtOAc amount (for detailed gradient see supplementary
able S-1) yielding 29 fractions (A1-A29). The methanol insolu-
le part (110.71 mg)  of fraction A18 (PE-(DCM–EtOAc) 40:60, v/v;
15.03 mg)  was recrystallized in acetone yielding 14.91 mg  of com-
ound 7. Identity was conﬁrmed by the analysis of spectroscopic
nd spectrometric data (1D- and 2D-NMR, MS) and comparison
ith published data [7],  see supplementary Table S-2 for NMR  data.
urity of all standards was ≥96% (determined by HPLC).
NMR: 1D- and 2D-experiments were measured on a Bruker
RX 300 (Bruker Biospin Rheinstetten, Germany) operating at
00.13 MHz  (1H) and 75.47 MHz  (13C) at 300 K; NMR  solvent:
cetone-d6 with 0.03% TMS  (Eurisotop Gif-Sur-Yvette, France),
hich was used as internal standard.
.3. HPLC sample preparation
Extract preparation. Dry plant material was grounded and sieved
mesh size 750 m).  Extraction of the powdered roots (around
00 mg)  was performed by using an Accelerated Solvent Extractor
ASE 100, DIONEX) with a mixture of DCM–acetone (95:5, v/v) as
olvent. Following parameters were applied: temperature 100 ◦C,
30% ﬂush volume, 5 cycles, static time 5 min, purge time 70 s. For
n exhaustive extraction the procedure was carried out twice. The 2
xtracts were combined and evaporated to dryness under reduced
ressure. Subsequently the residue was redissolved in methanolnd Biomedical Analysis 56 (2011) 546– 552 547
and quantitatively transferred into a volumetric ﬂask, adjusted to a
ﬁnal volume (5 ml)  with methanol and ﬁltered through a 0.45 m
nylon membrane ﬁlter (Phenomenex). Each sample was assayed in
triplicate. The amount found in the samples was calculated as per-
cent of the initial weight of the dried roots. In order to check if this
extraction protocol is exhaustive, another 5 cycles (after the nor-
mal  extraction protocol) were conducted and the obtained extract
analyzed by HPLC. None of the compounds 1–12 could be quan-
tiﬁed since their content was below the LOQ and even below the
LOD, indicating an exhaustive extraction.
Preparation of tinctures. Tinctura Ratanhiae (0.50 ml) samples
were directly applied on a small column ﬁlled with 300 mg
polyamide and eluted with methanol (5 ml). The eluate was evap-
orated under reduced pressure, redissolved in methanol (1 ml)  and
ﬁltered through a 0.45 m nylon membrane ﬁlter (Phenomenex).
In order to ﬁt the calibration range the obtained samples were
assayed directly for quantiﬁcation of compounds 1–7, 9–10,  12.  For
quantiﬁcation of compound 8 and 11 the obtained solutions were
further diluted with methanol 1:4 (v/v). Each sample was  assayed
in triplicate.
2.4. HPLC and HPLC–MS conditions
The quantitative analysis was  performed on a Shimadzu UFLC
XR (Kyoto, Japan) equipped with an auto sampler, PDA, an on-line
degasser and column thermostat. As stationary phase a Phe-
nomenex Luna Phenyl-Hexyl column (150 mm × 3 mm i.d., 3 m
particle size) was used. The composition of the mobile phase
consisted of 0.02% (v/v) TFA in water (solvent A) and acetonitrile-
methanol 75:25 (v/v; solvent B). Separation was  achieved by a
gradient analysis starting with 55A – 45B, increasing the amount
of solvent B in 30 min to 75% and 30.1 min  to 100% B, stop time
40 min. For equilibration a post time of 15 min was applied. Other
parameters: ﬂow rate 0.30 ml/min, injection volume 5 l, detection
wavelength 280 nm;  column temperature 35 ◦C.
HPLC–MS experiments were performed on an Esquire 3000
ion-trap mass spectrometer (Bruker-Daltronics, Bremen, Germany)
coupled to an Agilent HPLC system type HP 1100. MS  parame-
ters: ESI, alternating mode; spray voltage: 4.5 kV, 365 ◦C; dry gas:
9 l/min; nebulizer 40 psi; full scan mode: m/z 100–1500. Solvent
A was changed from 0.02% aqueous TFA to water for analysis of
extract samples, and to water with 0.9% formic acid and 0.1% acetic
acid for analysis of tincture samples. All other HPLC parameters
were maintained.
2.5. Calibration and validation
Individual stock solutions of standard compounds were pre-
pared in methanol. According to solubility different starting
concentrations were used: 2 mg/ml  for compound 2, 1 mg/ml for
compounds 1, 4–6, 8–10, and 12,  0.5 mg/ml  for compound 11,  and
0.3 mg/ml  for compound 7. Five additional calibration levels were
prepared by dilution with methanol, and each level was assayed in
triplicate (see Table 1 for calibration data).
Limits of Detection (LOD) and Limits of Quantitation (LOQ) were
calculated based on the calibration curve according to the ICH
guidelines. Peak purity was  assured by evaluating UV  data with the
“peak purity” option in the software and by HPLC–MS experiments.
Accuracy was  determined in sample RR-1 as well as in sample T-1
(T-2 in case of compound 4) by spiking experiments at two differ-
ent concentrations. Known amounts of the standard compounds
were added either to the dry powdered root material, followed by
extraction or were applied on the polyamide column together with
the tincture.
Repeatability of the method was assured by relative standard
deviations of multiple injections. Precision of the method was
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Table  1
Calibration data of compounds 1–12, including regression equation, correlation coefﬁcient (R2), linear range (g/ml), limit of detection (LOD; (g/ml), and limit of quantitation
(LOQ;  (g/ml).
Regression equat. R2 Linear range LOD LOQ
1 y = 49358.75x + 96.39 0.9998 1–500 0.46 1.40
2/3 y  = 9156.30x + 186.80 0.9993 3–1650 1.65 4.99
4  y = 21287.27x + 95.29 0.9997 30–1000 12.47 37.78
5 y  = 42402.89x + 70.31 0.9996 1.5–600 0.86 2.61
6  y = 58933.29x + 224.43 0.9991 0.7–400 0.65 1.97
7  y = 33407.79x + 39.08 0.9997 1–300 0.56 1.70
8  y = 35470.63x + 167.03 0.9982 1.5–480 0.75 2.27
9 y  = 71252.44x + 376.59 0.9984 4–500 1.70 5.15
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11 y  = 84781.86x + 200.42 0.9982 
12  y = 50084.95x + 187.11 0.9994 
etermined by preparing and assaying 5 replicate samples of RR-1
nd T-1 on the same day; the same procedure was repeated on two
ore days. By comparing variations within the same days intra-day
recisions were determined, by observing differences within the 3
ays inter-day precision was deduced.
. Results and discussion
.1. Isolation and identiﬁcation of standards
Compounds 1–6 and 8–12 were obtained and identiﬁed in a
revious study as:
5-(3-hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzo-
uran (1), (−)-larreatricin (2), meso-3,3′-didemethoxynectandrin B
3), (2S,3S)-2,3-dihydro-3-hydroxymethyl-2-(4-hydroxyphenyl)-
-(E)-propenylbenzofuran (4), 2-(2-hydroxy-4-methoxyphenyl)-
-(3-hydroxypropyl)benzofuran (5), 2-(2,4-dihydroxyphenyl)-
-(E)-propenylbenzofuran (6), (+)-conocarpan (8), 2-(4-
ydroxyphenyl)-5-(E)-propenylbenzofuran (9), rataniaphenol
II (10), rataniaphenol II (11), and rataniaphenol I (12) (see Fig. 1
or structures) [10]. In the course of the present work com-
ound 7, one additional prominent peak, was isolated out of
he roots of K. lappacea. By mass spectrometry, 1- and 2D-NMR
xperiments and comparison with published data [7] this lignan
erivative was identiﬁed as 3-formyl-2-(4-hydroxyphenyl)-5-(E)-
ropenylbenzofuran.
.2. Method development
The major problem in the development of a HPLC method for
he simultaneous detection of all active lignan derivatives was  the
tructural similarity of the analytes. In order to accomplish a sat-
sfactory separation, all parameters had to be carefully assessed.
he initial screening experiments (stationary phases with RP-12,
P-18, ether-linked phenyl, phenyl-hexyl column material) clearly
howed that the stationary phase had to be a phenyl-hexyl col-
mn, since this phase exclusively enabled the baseline separation
f ratanhiaphenols II (11) and I (12), which represent the most
rominent constituents in Ratanhiae radix. Moreover it was obvi-
us that by using just methanol or acetonitrile alone no satisfactory
eparation was achieved. Several mixtures thereof (25:75, 50:50,
5:25; all v/v) were assayed; best resolution was achieved with
cetonitrile-methanol 75:25 (v/v) at 35 ◦C. An acidic mobile phase
as not mandatory, but improved peak shape of analytes and sepa-
ation of unwanted constituents (tannins) in the tincture samples.
herefore 0.02% TFA was added to solvent A (water). The wave-
ength was set to 280 nm,  since it enabled the sensitive detection
f all analytes. With this method a baseline separation of com-
ounds 1–12 (besides the stereoisomers 2 and 3) was possible in
ess than 30 min  (see Fig. 2). One problem emerged at the begin-
ing of sample analysis when evaluating purity of all analytes3.5–500 1.45 4.38
1–180 0.41 1.25
1.5–600 0.74 2.23
by the use of the UV purity function of the used HPLC software:
stereoisomers 2/3 showed in the root samples as well as in the tinc-
tures a co-elution with small amounts of an additional compound.
Attempts to improve the resolution with the aid of additives, such
as tetrahydrofuran, 1-, and 2-propanol or tert-butylmethyl ether,
or a variation of temperature showed no effect. Separation was
possible by changing the stationary phase from the phenyl-hexyl
material to a RP-12 column material, but as highlighted before this
made a separation of compounds 11 and 12 impossible. Since these
two  constituents are very prominent compounds in the roots of
K. lappacea, the impurity was accepted and the content of the 2
7,7′-epoxylignan derivatives was  only estimated in the presented
study.
For HPLC–MS experiments solvent A was changed from 0.02%
aqueous TFA to water in case of root samples, and to 0.9% formic acid
and 0.1% acetic acid for analysis of tinctures. All other parameters
were maintained.
3.3. Method validation
Suitability of the developed method for the quantiﬁcation of the
major lignan derivatives in Ratanhiae radix and Tinctura Ratanhiae
can be deduced from several analytical parameters. The detector
signal was linear in the tested range with a correlation coefﬁ-
cient higher than 0.9982, calibration data for compounds 1–12 is
shown in Table 1. Limits of detection (LOD) and limits of quanti-
tation (LOQ), indicating the sensitivity of the method, ranged from
0.41–1.70 g/ml to 1.25–5.15 g/ml, respectively. Only for com-
pound 4 LOD (12.47 g/ml) and LOQ (37.78 g/ml) were higher.
MS and UV spectra showed that all analytes, besides 2/3, were free
of co-eluting compounds or impurities. Together with the fact that
all compounds, except the stereoisomers 2 and 3, were baseline
separated, selectivity of the assay is indicated.
Accuracy was  determined in recovery experiments where 2 dif-
ferent concentrations of standard compounds were added either
to the plant material (RR-1) before extraction or applied on top
of the polyamide column together with the tincture (normally T-
1; T-2 in case of compound 4). All results were within the usually
required recovery range of 100 ± 5%, as shown in supplementary
Tables S-3 and S-4. Maximum deviations were reached for com-
pound 1 (recovery at low spike in tincture 95%) and compound
6 (recovery rate at low spike in extract 105.2%), respectively.
Relative standard deviations below 4.55% and very stable reten-
tion times during the whole study implicate the repeatability of
the developed method. Precision of the whole assay was deter-
mined on three following days (see Table 2A and B). Maximum
deviations within one day (intra-day precision) were 4.67% for com-
pound 12 in the extract and 4.78% for compound 7 in the tincture.
Compound 7 showed highest inter-day variance with maximum
deviations of 2.98% in the extract and 3.38% in the tincture,
respectively.
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.4. Sample analysisPreliminary tests were performed in order to determine opti-
um  sample preparation conditions for the root as well as the
incture samples. In the case of root samples, different solvents
able 2
ntra- and inter-day precision of the developed HPLC-assay using sample RR-1 (A) and T-
(A) Intra-day (n = 5) 
Day 1 Day 2 
1 2110.6 (2.9) 2169.4 (3.1) 
4  <LOQ <LOQ 
5  1978.6 (2.5) 1974.2 (2.9) 
6  3403.7 (4.4) 3224.4 (4.2) 
7 1156.4 (3.2) 1115.5 (4.4)
8  5079.3 (2.4) 5036.5 (2.9) 
9  1174.1 (3.8) 1149.7 (4.1) 
10  2808.3 (3.5) 2780.6 (2.9) 
11  9185 (2.5) 9152.1 (3.6) 
12  2252.7 (4.1) 2252.5 (4.2) 
(B)
1  1556.1 (1.3) 1517.1 (1.5) 
4  <LOQ <LOQ 
5  1617.9 (1) 1567.3 (1.5) 
6  2711.8 (3.1) 2632.9 (1.4) 
7 736.5 (1.3) 713 (4.8) 
8  2937.7 (2.9) 2848.6 (2) 
9  761.2 (1) 734.7 (4.5) 
10 1115.7  (1.3) 1061.9 (0.9) 
11  6263 (0.5) 6117.1 (0.7) 
12 1855 (1.5) 1889.9 (1.8) alyzed lignan derivatives.
(methanol, acetone, DCM and mixtures thereof) and extrac-
tion procedures (sonication, ASE extraction) were evaluated. ASE
extraction (2 times 5 cycles for 5 min  at 100 ◦C) with a mix-
ture of DCM–acetone (95:5, v/v) was most efﬁcient. Following
these conditions the lignan derivatives were exhaustively extracted
1 (B); results are based on peak area, relative standard deviation in parenthesis.
Inter-day (n = 3)
Day 3
2114.9 (3.5) 2131.6 (1.3)
<LOQ <LOQ
1992.6 (3.3) 1981.8 (0.4)
3210.3 (3.3) 3279.5 (2.7)
1074.9 (3.5) 1115.6 (2.9)
4998.2 (2.2) 5038 (0.7)
1123.5 (4.1) 1149.1 (1.8)
2719.9 (3) 2769.6 (1.3)
9102.1 (3.1) 9146.4 (0.4)
2217.7 (4.7) 2241 (0.7)
1510.7 (1.5) 1528 (1.3)
<LOQ <LOQ
1587.5 (1.4) 1590.9 (1.3)
2646.5 (2.3) 2663.7 (1.3)
678.1 (3.2) 709.2 (3.4)
2863.2 (2.4) 2883.2 (1.4)
738.2 (1.7) 744.7 (1.6)
1079.7 (1.4) 1085.8 (2.1)
6121.6 (1.4) 6167.2 (1.1)
1938.8 (1.6) 1894.6 (1.8)
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Fig. 2. Separation of a standard mixture of compounds 1–12, and samples RR-1, and T-1 under optimized HPLC conditions (column Luna Phenyl-hexyl, 150 mm × 3 mm,
3 ) (B); g
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M m;  mobile phase: 0.02% (v/v) TFA in water (A), acetonitrile:methanol 75:25 (v/v
ate:  0.3 ml/min; injection volume: 5 l; temperature: 35 ◦C; detection: 280 nm).
ut the yield of undesired tannins could be minimized. For the
nalysis of Tinctura Ratanhiae samples (containing ≥1% (m/m)
annins according to the Ph. Eur.) interfering tannins had to be
liminated. For this purpose 2 methods, liquid–liquid extraction
DCM–water) and separation over polyamide, were evaluated.
ptimal results were obtained by applying the tincture samples
irectly on top of a polyamide column followed by elution with
ethanol. Chromatograms of the standard mix, a typical root
nd a tincture sample under optimized conditions are depicted in
ig. 2.
All compounds were well resolved and could be assigned by
omparison of their retention times, UV-spectra of the respective
tandards, and by HPLC–MS experiments (ESI, alternating mode). In
rder to present the results in a clear form the extracted ion chro-
atograms (EIC) were selected for presentation (see Fig. 3). The
S  signals of the 7,7′-epoxylignans 2/3 were assigned as [M+H]+,radient: 55A-45B in 30 min to 25A-75B, in 0.1 min  to 100B, stop time 40 min; ﬂow
and compound 9 as [M]−. All other benzofuran derivatives were
assignable as [M−H]−.
Three root samples (RR-1 to RR-3) and four ethanolic tinctures
(T-1 to T-4), 3 of them were purchased in pharmacies around
Austria, were analyzed during this study, the obtained results are
illustrated in Table 3. The major compounds in all samples were
(+)-conocarpan (8) and ratanhiaphenol II (11) with contents of
0.49–0.71% and 0.51–0.53% in the roots as well as 0.19-0.68 mg/ml
and 0.16-0.71 mg/ml  in the tinctures, respectively. The content
of the stereoisomer mixture 2/3, ranging from 0.11–0.23% in the
roots to 0.20–0.29 mg/ml  in the commercial tinctures (T-2 to T-4),
can only be estimated due to the observed co-elution. Interest-
ingly, root sample RR-1 showed a higher content of all benzofurans,
except for compounds 6, and 11.  Highest deviations within the root
samples were found for compounds 5 and 12 with contents rang-
ing from 0.06–0.22% to 0.08–0.20%, respectively. Compound 4 was
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Fig. 3. HPLC–MS analysis of sample RR-1; HPLC-conditions according to Fig. 2 except solvent A (water); MS-conditions: ESI alternating mode, nebulizer 40 psi, spray voltage
4.5  kV, 365 ◦C, dry gas: 9 l/min; EIC: extracted ion chromatogram.
Table 3
Quantitative results for compounds 1 and 4–12 in Tinctura Ratanhiae samples T-1 to T-4 and Ratanhiae radix samples RR-1 to RR-3; relative standard deviations in parenthesis
(n  = 3).
T-1 (mg/ml) T-2 (mg/ml) T-3 (mg/ml) T-4 (mg/ml) RR-1 mg/100 mg RR-2 mg/100 mg  RR-3 mg/100 mg
1 0.07 (1) 0.21 (1.07) 0.21 (2.05) 0.19 (0.81) 0.20 (2.18) 0.15 (4.43) 0.15 (2.32)
4  <LOQ 0.08 (2.23) 0.08 (3.75) 0.07 (1.24) <LOQ <LOQ <LOQ
5  0.09 (0.87) 0.10 (1.39) 0.09 (2.81) 0.07 (0.96) 0.22 (1.53) 0.07 (0.33) 0.06 (2.79)
6  0.10 (2.11) 0.34 (1.78) 0.34 (1.55) 0.31 (4.06) 0.26 (1.48) 0.29 (2.85) 0.29 (1.89)
7  0.05 (1.17) 0.15 (0.68) 0.15 (2.12) 0.10 (1.85) 0.17 (4.35) 0.10 (3.30) 0.11 (3.52)
8  0.19 (1.03) 0.66 (3) 0.66 (1.66) 0.68 (2.87) 0.71 (2.43) 0.51 (4.55) 0.49 (2.59)
9  0.01 (2.01) 0.06 (0.68) 0.06 (1.61) 0.07 (1.42) 0.05 (1.52) 0.03 (3.42) 0.03 (4.20)
1  (0.73)
1  (1.74)
1  (0.97)
b
t
A
d
t
a
l
w0  0.04 (1.60) 0.32 (1.08) 0.33 (0.73) 0.35
1  0.16 (0.44) 0.71 (1.91) 0.70 (1.80) 0.71
2  0.08 (2.82) 0.12 (1.40) 0.12 (0.83) 0.11
elow LOQ in all root samples and sample T-1, but could be quan-
iﬁed in the commercial tinctures (T-2 to T-4; 0.07–0.08 mg/ml).
s expected T-1 contained 2-4 times lower amounts of the lignan
erivatives. This issue could be explained by the shorter macera-
ion time (3 days), since regular Tinctura Ratanhiae is prepared by
 double maceration over a period of two weeks. The content of the
ignan derivatives in the tincture samples 2–4 was very consistent
ith the highest variation for compound 7 (0.10–0.15 mg/ml). 0.22 (3.77) 0.27 (0.96) 0.29 (3.55)
 0.53 (3.20) 0.52 (4.40) 0.51 (2.39)
 0.20 (4.34) 0.08 (2.88) 0.09 (2.98)
4. Conclusions
In a previous study we  could show that not only tannins with
their astringent and antimicrobial properties, but also the neglected
compound class of lignan derivatives with their pronounced anti-
inﬂammatory activities play an important role in the use of the
herbal drug against inﬂammatory disorders of mouth and throat.
Thus, the HPLC-method, developed in the present study, is a sig-
5 tical a
n
t
r
b
p
t
A
S
o
A
t
R
[52 L. Baumgartner et al. / Journal of Pharmaceu
iﬁcant improvement and innovation, since it enables for the ﬁrst
ime the quantitative analysis of lignan derivatives in Ratanhiae
adix as well as in Tinctura Ratanhiae. This validated assay will
e a useful tool for quality control of the plant material and its
reparations, focusing on the compound class of lignan deriva-
ives.
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